Good Biotech Corp is the one and only one patent owner of "IgY(ΔFc) antibody's manufacture & applications" in the world. This commercialized technology is solely owned by Good Biotech Corp. as well as patent-protected worldwide including all the major and dominant markets. Until now, 43 patents have been granted in the United States, Canada, Japan, European Union, Russia, Australia, China, Taiwan, New Zealand, Singapore, Korea, Malaysia, Mexico, Hong Kong and Israel, Brazil etc.
